Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC)
- PMID: 32253071
- DOI: 10.1016/j.diagmicrobio.2020.115024
Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC)
Abstract
Background: It is commonly stated that Candida in the vagina prefers a low pH to develop infection. However, mixed infections of Candida with bacterial vaginosis (BV) and aerobic vaginitis (AV) are rather common and may challenge the rule that Candida should only be looked for in low vaginal pH settings. In this study we tested whether the vaginal pH in acute vaginal candidosis is lower than in women successfully treated to prevent Candida recurrences.
Methods: Vaginal pH and microscopy findings of vaginal microbiota were recorded during 12 visits over 1.5 years in 117 patients medically monitored during a degressive fluconazole maintenance regimen for proven recurrent vulvovaginal candidosis (ReCiDiF trial). The fluctuation of the mean pH of and microscopic findings of the vaginal smears were studied before, during and after the treatment.
Results: The mean vaginal pH of women with acute infection before or after ending maintenance treatment was (4.7±0.8 and 4.8 ±1.0, respectively, p>0.05). During maintenance treatment with fluconazole, the pH dropped significantly to 4.5±0.8 (p=0.01). Depression of Lactobacilli spp. (increased lactobacillary grades) was more frequent during the acute, pre-treatment period (30.0%) than during the treatment period (23.1%, p=0.03). Aerobic vaginitis type flora was also more prevalent pre-treatment than during treatment (30.0% vs 22.2%, OR=0.7 (95%CI 0.5-0.9), p=0.01).
Discussion: In women with RVVC, acute vaginal Candida infection is associated with an increased pH, and disturbed vaginal bacterial microbiota. During fluconazole maintenance treatment, the pH drops to normal levels and the lactobacillary grade improves.
Condensation: Acute Candida vulvovaginitis can be associated with a disturbance of the vaginal microbiota. In patients with recurrent vulvovaginal candidosis, decrease of pH, and increase of Lactobacilli spp. were observed during fluconazole maintenance treatment. This pH drop was seen in all response groups. This contradicts the common belief that active vaginal Candida infection is related to low pH.
Keywords: Aerobic vaginitis; Bacterial vaginosis; Candida albicans; Candida non-albicans; Therapy; Vaginal dysbiosis; Vulvovaginitis.
Copyright © 2020. Published by Elsevier Inc.
Similar articles
-
The impact of fluconazole use on the fungal and bacterial microbiomes in recurrent Vulvovaginal Candidiasis (RVVC): a pilot study of vaginal and gastrointestinal site interplay.Eur J Clin Microbiol Infect Dis. 2025 Feb;44(2):285-301. doi: 10.1007/s10096-024-04999-1. Epub 2024 Nov 26. Eur J Clin Microbiol Infect Dis. 2025. PMID: 39586933 Free PMC article.
-
Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).Mycoses. 2015 Mar;58 Suppl 1:1-15. doi: 10.1111/myc.12292. Mycoses. 2015. PMID: 25711406
-
Is multiple-site colonization with Candida spp. related to inadequate response to individualized fluconazole maintenance therapy in women with recurrent Candida vulvovaginitis?Diagn Microbiol Infect Dis. 2018 Nov;92(3):226-229. doi: 10.1016/j.diagmicrobio.2018.05.024. Epub 2018 Jun 2. Diagn Microbiol Infect Dis. 2018. PMID: 30293562
-
Interplay of the microbiome and antifungal therapy in recurrent vulvovaginal candidiasis (RVVC): A narrative review.J Med Microbiol. 2023 May;72(5). doi: 10.1099/jmm.0.001705. J Med Microbiol. 2023. PMID: 37171871 Review.
-
Recurrent vulvovaginal candidiasis.Am J Obstet Gynecol. 2016 Jan;214(1):15-21. doi: 10.1016/j.ajog.2015.06.067. Epub 2015 Jul 9. Am J Obstet Gynecol. 2016. PMID: 26164695 Review.
Cited by
-
Intravaginal Combination Therapy of Acetic and Lactic Acid in premenopausal women with recurrent vulvovaginal candidiasis: A randomized, double-blind placebo-controlled feasibility trial.Womens Health (Lond). 2023 Jan-Dec;19:17455057231194138. doi: 10.1177/17455057231194138. Womens Health (Lond). 2023. PMID: 37635435 Free PMC article. Clinical Trial.
-
A clinical pilot study on the effect of the probiotic Lacticaseibacillus rhamnosus TOM 22.8 strain in women with vaginal dysbiosis.Sci Rep. 2021 Jan 28;11(1):2592. doi: 10.1038/s41598-021-81931-z. Sci Rep. 2021. PMID: 33510271 Free PMC article.
-
Phenylacetic acid, an anti-vaginitis metabolite produced by the vaginal symbiotic bacterium Chryseobacterium gleum.Sci Rep. 2024 May 28;14(1):12226. doi: 10.1038/s41598-024-62947-7. Sci Rep. 2024. PMID: 38806600 Free PMC article.
-
Exogenous Reproductive Hormones nor Candida albicans Colonization Alter the Near Neutral Mouse Vaginal pH.Infect Immun. 2021 Jan 19;89(2):e00550-20. doi: 10.1128/IAI.00550-20. Print 2021 Jan 19. Infect Immun. 2021. PMID: 33106292 Free PMC article.
-
The impact of fluconazole use on the fungal and bacterial microbiomes in recurrent Vulvovaginal Candidiasis (RVVC): a pilot study of vaginal and gastrointestinal site interplay.Eur J Clin Microbiol Infect Dis. 2025 Feb;44(2):285-301. doi: 10.1007/s10096-024-04999-1. Epub 2024 Nov 26. Eur J Clin Microbiol Infect Dis. 2025. PMID: 39586933 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous